Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults.
about
Particularities of allergy in the TropicsHealth education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of BrazilStructure of a two-CAP-domain protein from the human hookworm parasiteNecator americanusAn immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areasVaccines to combat the neglected tropical diseases.Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepaticaSafety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.The genome and developmental transcriptome of the strongylid nematode Haemonchus contortusGene expression patterns in larval Schistosoma mansoni associated with infection of the mammalian host.The impact of perception and knowledge on the treatment and prevention of intestinal worms in the Manikganj district of BangladeshThe potential economic value of a hookworm vaccine.Selection and quantification of infection endpoints for trials of vaccines against intestinal helminthsUse of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomesImmunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice.A history of hookworm vaccine development.The genomic basis of parasitism in the Strongyloides clade of nematodesAdvances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine.Cracking the nodule worm code advances knowledge of parasite biology and biotechnology to tackle major diseases of livestock.Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndromeGlycoconjugates in host-helminth interactionsMultivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.Deep insights into Dictyocaulus viviparus transcriptomes provides unique prospects for new drug targets and disease interventionBioinformatics meets parasitology.Future prospects and challenges of vaccines against filariasis.Controlling soil-transmitted helminths: time to think inside the box?Microorganism-induced suppression of allergic airway disease: novel therapies on the horizon?Recombinant subunit vaccines for soil-transmitted helminths.Global trends in neglected tropical disease control and elimination: impact on child health.Twenty-first century progress toward the global control of human hookworm infection.Fusion of Na-ASP-2 with human immunoglobulin Fcγ abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE.Schistosoma mansoni cercarial elastase (SmCE): differences in immunogenic properties of native and recombinant forms.Onchocerca volvulus: The Road from Basic Biology to a Vaccine.A novel blood-feeding detoxification pathway in Nippostrongylus brasiliensis L3 reveals a potential checkpoint for arresting hookworm development.Metazoan Parasite Vaccines: Present Status and Future Prospects.Evaluation of parasitological and immunological aspects of acute infection by Ancylostoma caninum and Ancylostoma braziliense in mixed-breed dogs
P2860
Q26314626-83566663-256F-42E6-9803-042C7519E47FQ27306739-EC6C5E70-B68E-4622-9CCF-012E10597C23Q27667719-AFCE210D-EDC9-46A4-9469-26F784C986D5Q28541675-CA3085C6-83BF-4200-B7E0-DD935FB35FCAQ30425005-2B999565-940E-4F96-A6D7-8B67EE8A20BBQ33550595-4D675794-B6CA-4EEB-B312-C6DDDCBCD623Q33719126-CC1DAB43-9132-465A-B0CA-F04E9F64CC99Q33741666-79F28B9D-DA8C-45E0-ACDB-DE065D525E7EQ34017999-3A4CDC9E-6529-4801-8583-F8D739671688Q34407253-468DE196-A286-490E-A0BB-D1A76D950075Q34572067-7582FC13-0FD7-4F86-984C-7020C18DDE29Q34978256-E24A93A2-1FF2-41DF-ABB3-E9E2544CC4AAQ35156323-463C27B5-F31B-4029-8E4C-89EB345D21B2Q35317663-7BD001C6-023B-42F5-A235-6ACD0A93C652Q35881296-A284BCDB-4F9F-4AF9-8A7F-ACDFDB6EFDDDQ35909943-74972CE4-94AB-4D5E-B37C-61AECDD6B77BQ36278451-AD72434D-5EBD-4630-8365-FAD418CD790AQ36558899-BF76C78A-01A3-4B5F-93AB-BC0914BE7E70Q36650501-A6325CE0-0C88-4224-8EE8-D44F9C1F17DDQ37126736-8C03FBCE-1B81-4C0F-8D16-6D325EEED172Q37229920-584AD170-1408-4B53-8369-F8EABD54E541Q37307451-4E4C9B38-B6D3-4F0F-897B-B9B68783086EQ37880170-00D012BE-4651-489B-BCF1-E32DDB4A317FQ37965765-042736D4-7033-427A-9E7D-D25143E16527Q38176075-9D5C84BA-8C43-4925-847E-855E857BB88DQ38241379-5C54B476-3F1C-4F3A-981A-F5BE07418F7EQ38647737-B72A88A6-64F1-4CE2-9A8E-BAFABCECF126Q38894845-B73B6C23-FE37-41B8-92D4-30D3CB14EA63Q38925668-C11DC0E0-74AD-49C4-A6A7-A3E8D28A5055Q39624915-BFDC30B0-461F-4C80-BB1D-ACCB9A328509Q40106676-9875836F-0071-4942-B3F9-74B39F515241Q46299379-1E0DE287-A3BF-4C93-8908-48C3C63F7208Q51730343-5D8206A5-CD37-45DC-8F54-54E3E58E4B4CQ55024731-302D6290-85E8-4D7A-AFFE-2B0EA4E28551Q58853077-A1313991-FC1E-4153-A1BE-7C4BD5767BB3
P2860
Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@ast
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@en
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@nl
type
label
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@ast
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@en
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@nl
prefLabel
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@ast
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@en
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@nl
P2093
P50
P1433
P1476
Randomized, placebo-controlled ...... m vaccine in unexposed adults.
@en
P2093
Aimee Desrosiers
David Parenti
Gary Simon
Jeffrey M Bethony
Suzanne Schuck
P304
P356
10.1016/J.VACCINE.2008.02.049
P407
P577
2008-03-11T00:00:00Z